11 Best Bear Market Stocks To Invest In Now

Page 3 of 11

9. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 81

Johnson & Johnson (NYSE:JNJ) researches and develops, manufactures, and sells various products in the healthcare field. This company emerges as a prime investment opportunity for several reasons. First and foremost, the report for the fiscal year 2024 shows the company’s core operational performance. For instance, the reported earnings per share (EPS) was $1.41, and the adjusted EPS was $2.04. Moreover, the company reported sales growth of 5.3% to $22.5 billion, which indicates a solid increase in revenue. The operational growth of 6.7% shows the company’s stellar performance from its core business operations, excluding external factors like currency fluctuations. The company has a 5-year growth rate of 5.54% that reflects a consistent commitment to growing shareholder returns through dividends, signaling financial stability. Lastly, Johnson & Johnson has strengthened neuroscience leadership with the acquisition of Intra-Cellular Therapies.

Page 3 of 11